Press releaseGlobe Newswire
Artiva Biotherapeutics
ARTV · NASDAQ
$6.56+$0.67 (+11.38%)TodayMarket closed ·
Prev close $5.89
Latest news
- Press releaseGlobe Newswire
Artiva Biotherapeutics Highlights Updated AlloNK® Data in Sjögren Disease Presented at the 17th International Symposium on Sjögren’s Disease (ISSjD 2026)
- Press releaseGlobe Newswire
Artiva Biotherapeutics Announces Oral Presentation of AlloNK® Clinical Data at the 17th International Symposium on Sjögren’s Disease
- Press releaseGlobe Newswire
Artiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation Forum
- Press releaseGlobe Newswire
Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026
- NewsTim Melvin
Alpha Buying: 4 Biotech Stocks a Healthcare Specialist Is Buying
- Press releaseGlobe Newswire
Artiva Biotherapeutics to Participate in Upcoming Investor Conferences in September
- Press releaseGlobe Newswire
Artiva Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
- Press releaseGlobe Newswire
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
- NewsAvi Kapoor
Why Cracker Barrel Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
- Press releaseGlobe Newswire
Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today
- Press releasePRNewswire
The $13 Million Company Teaching the Immune System to Hunt Cancer
- Press releasePRNewswire
Solid Tumor Treatment Race Heats Up as Multi-Billion-Dollar Oncology Market Enters High-Growth Phase
- NewsVandana Singh
Artiva Biotherapeutics Stock Slides Despite Positive Trial Data
- News
12 Health Care Stocks Moving In Friday's Pre-Market Session
- News
Market-Moving News for May 8th
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- NewsAvi Kapoor
Sonoco Products Posts Downbeat Q1 Results, Joins Target Hospitality, Calix And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
- Press releasePRNewswire
Seasoned biotherapeutics leader Thomas J. Farrell joins NanoSyrinx as CEO to advance Nanosyringe-enabled intracellular medicines
- News
12 Health Care Stocks Moving In Monday's After-Market Session
- NewsAvi Kapoor
Crude Oil Falls Over 1%; US Homebuilder Sentiment Edges Higher In December
- News
12 Health Care Stocks Moving In Monday's Intraday Session
- NewsAvi Kapoor
US Stocks Mixed; NY Manufacturing Activity Dips In December
- News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
- NewsAlex Perry
Why Is Artiva Up Today?
- NewsAvi Kapoor
Gold Falls 1%; SLB Posts Better-Than-Expected Q3 Earnings
- NewsAvi Kapoor
Dow Gains Over 100 Points; American Express Increases 2025 Forecast
- News
Market-Moving News for October 17th
- NewsAvi Kapoor
Why CSX Shares Are Trading Higher By Over 4%; Here Are 20 Stocks Moving Premarket
- News
12 Health Care Stocks Moving In Wednesday's After-Market Session
- Press releaseBusiness Wire
ArrePath Announces Closing of Their Next Financing Round and Appointment of a New Board Chair
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.